None listed
Conditions
Interventions
Intervention1: Biweekly Iron Folic Acid with 30 mg iron: IFA tablets having 30 mg iron and 250 mcg folic acid will be administered twice weekly
Control Intervention1: Weekly Iron Folic Acid with 60 mg
Sponsors
State Health System Resource Center, Gujarat
Eligibility
Inclusion criteria
Inclusion criteria: Adolescent girls in their middle or late adolescent age (14 to 19 years), who herself or whose parents are ready to give written informed assent /consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Adolescent girl who will be anemic at the time of baseline assessment. 2.Adolescent girl who is already on Iron therapy for treatment of anemia. 3.Adolescent girl who is diagnosed with hemoglobinopathies (Sickle cell anemia, Thalassemia major/minor). 4. Adolescent girl who is currently having any kind of systemic illness (Tuberculosis, Diabetes, Hypertension, Thyroid disorders etc.) which requires treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance to Iron and Folic Acid (IFA) supplementation, measured as Proportion of prescribed IFA tablets consumed over the study period, assessed by pill count and/or self-reported intake, compared between weekly 60 mg and twice-weekly 30 mg regimens.Timepoint: End of intervention period, 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency and type of self-reported side effectsTimepoint: During intervention period;Hemoglobin levelTimepoint: Baseline and end of intervention | — |
Countries
India
Contacts
Public ContactDr Venu Shah
GCS Medical College, Ahmedabad
Outcome results
None listed